Cargando…
Inhibition of 11β-HSD1 Expression by Insulin in Skin: Impact for Diabetic Wound Healing
Chronic, non-healing wounds impose a great burden on patients, professionals and health care systems worldwide. Diabetes mellitus (DM) and obesity are globally highly prevalent metabolic disorders and increase the risk for developing chronic wounds. Glucocorticoids (GCs) are endogenous stress hormon...
Autores principales: | Brazel, Christina B., Simon, Jan C., Tuckermann, Jan P., Saalbach, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760287/ https://www.ncbi.nlm.nih.gov/pubmed/33260645 http://dx.doi.org/10.3390/jcm9123878 |
Ejemplares similares
-
Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial
por: Ajjan, R A, et al.
Publicado: (2022) -
PEDF Expression Is Inhibited by Insulin Treatment in Adipose Tissue via Suppressing 11β-HSD1
por: Zhou, Yinli, et al.
Publicado: (2013) -
Inhibition of 11β-HSD1 by Tetracyclic Triterpenoids from Euphorbia kansui
por: Guo, Jie, et al.
Publicado: (2012) -
Overexpression of S100A9 in obesity impairs macrophage differentiation via TLR4-NFkB-signaling worsening inflammation and wound healing
por: Franz, Sandra, et al.
Publicado: (2022) -
11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes
por: Peng, Kesong, et al.
Publicado: (2016)